NCT01870102View on ClinicalTrials.gov

Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

August 31, 2013

Conditions
Healthy Males
Interventions
DRUG

Pelubiprofen IR (Pelubiprofen 30mg) TID

DRUG

Pelubiprofen SR (Pelubiprofen 45 mg) BID

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY